Pathfinder Bancorp, Inc. Debt Disclosure
NOTE 12: BORROWED FUNDS
The composition of borrowings (excluding subordinated debt) at December 31 is as follows:
(In thousands) |
|
2024 |
|
|
2023 |
|
||
Short-term: |
|
|
|
|
|
|
||
FHLB advances |
|
$ |
61,000 |
|
|
$ |
125,680 |
|
Total short-term borrowings |
|
$ |
61,000 |
|
|
$ |
125,680 |
|
Long-term: |
|
|
|
|
|
|
||
FHLB advances |
|
$ |
27,068 |
|
|
$ |
49,919 |
|
Total long-term borrowings |
|
$ |
27,068 |
|
|
$ |
49,919 |
|
The principal balances, interest rates and maturities of the outstanding long-term borrowings, all of which are at a fixed rate, at December 31, 2024 are as follows:
Term |
|
Principal |
|
|
Rates |
|
(Dollars in thousands) |
|
|
|
|
|
|
Advances with FHLB |
|
|
|
|
|
|
Due within 1 year |
|
$ |
23,883 |
|
|
0.52 - 4.92% |
Due within 2 years |
|
|
3,185 |
|
|
0.67 - 4.96% |
Total advances with FHLB |
|
$ |
27,068 |
|
|
|
Total long-term fixed rate borrowings |
|
$ |
27,068 |
|
|
|
At December 31, 2024, scheduled repayments of long-term debt are as follows:
(In thousands) |
|
|
|
|
2025 |
|
$ |
23,883 |
|
2026 |
|
|
3,185 |
|
Total |
|
$ |
27,068 |
|
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.